{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:28:42Z","timestamp":1788485322886,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"CSC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijpharm.2019.02.014","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T07:07:45Z","timestamp":1550473665000},"page":"377-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2\/HT29 co-culture monolayers and intra-jejunal instillation in rats"],"prefix":"10.1016","volume":"560","author":[{"given":"Jingying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Besenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Saaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Fan\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-3931","authenticated-orcid":false,"given":"Huiling","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-8892","authenticated-orcid":false,"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2019.02.014_b0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17425247.2016.1160889","article-title":"Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles","volume":"13","author":"Ahmad","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2012.10.003","article-title":"Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs","volume":"83","author":"Antunes","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/1520915041705929","article-title":"The physiological rationale for oral insulin administration","volume":"6","author":"Arbit","year":"2004","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2014.03.017","article-title":"A tunable Caco-2\/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure","volume":"87","author":"B\u00e9duneau","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2017.12.027","article-title":"Do drug release studies from SEDDS make any sense?","volume":"271","author":"Bernkop-Schn\u00fcrch","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1208\/s12248-014-9634-3","article-title":"Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid \u2013 Derivative","volume":"16","author":"Brayden","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201052772834","article-title":"Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery","volume":"2","author":"Cano-Cebrian","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0045","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1023\/A:1018927402875","article-title":"Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides","volume":"11","author":"Constantinides","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1023\/A:1016030812272","article-title":"Water-in-oil microemulsions containing medium-chain fatty acids\/salts: formulation and intestinal absorption enhancement evaluation","volume":"13","author":"Constantinides","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10611860290022688","article-title":"Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats","volume":"10","author":"Eaimtrakarn","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejpb.2009.06.004","article-title":"Formulation and characterization of an oily-based system for oral delivery of insulin","volume":"73","author":"Elsayed","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","article-title":"Protein drug stability: a formulation challenge","volume":"4","author":"Frokjaer","year":"2005","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2017.02.019","article-title":"Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems","volume":"520","author":"Griesser","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.foodres.2017.06.002","article-title":"Quantification of egg ovalbumin hydrolysate-derived anti-hypertensive peptides in an in vitro model combining luminal digestion with intestinal Caco-2 cell transport","volume":"99","author":"Grootaert","year":"2017","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jconrel.2013.05.002","article-title":"A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine","volume":"172","author":"Gupta","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0085","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.xphs.2018.02.012","article-title":"Labrasol\u00ae and salts of medium-chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae","volume":"107","author":"Heade","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(94)00232-T","article-title":"Drug delivery studies in Caco-2 monolayers. II. Absorption enhancer effects of lysophosphatidylcholines","volume":"114","author":"Hovgaard","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0095","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2015.04.013","article-title":"Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems","volume":"97","author":"Karamanidou","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0105","first-page":"G475","article-title":"Fate of pancreatic enzymes during small intestinal aboral transit in humans. American Journal of Physiology-Gastrointestinal and Liver","volume":"251","author":"Layer","year":"1986","journal-title":"Physiology"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0110","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/jps.23640","article-title":"Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems","volume":"102","author":"Li","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2014.10.039","article-title":"Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading","volume":"477","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0120","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.xphs.2016.01.006","article-title":"Impact of lipid-based drug delivery systems on the transport and uptake of insulin across caco-2 cell monolayers","volume":"105","author":"Li","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0125","doi-asserted-by":"crossref","unstructured":"Liu, J., Fan\u00f8, M., Mu, H. and M\u00fcllertz, A., 2019. Development of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis. Unpublished manuscript.","DOI":"10.1016\/j.ejps.2020.105272"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0130","unstructured":"Lind, M.L., 2009. Mechanisms for oral absorption of poorly water-soluble compounds. K\u00f8benhavn: Department of Pharmaceutics and Analytical Chemistry, The Faculty of Pharmaceutical Sciences, University of Copenhagen, Print. ISBN: 978-87-91430-23-7."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0135","first-page":"362","article-title":"Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells","volume":"284","author":"Lindmark","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/js990094e","article-title":"Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers","volume":"88","author":"Liu","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","article-title":"Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin","volume":"232","author":"Lopes","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0155","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/mp500626a","article-title":"Absorption mechanism of a physical complex of monomeric insulin and deoxycholyl-l-lysyl-methylester in the small intestine","volume":"12","author":"Mahmud","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cis.2016.03.002","article-title":"Natural emulsifiers-biosurfactants, phospholipids, biopolymers, and colloidal particles: molecular and physicochemical basis of functional performance","volume":"234","author":"McClements","year":"2016","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0165","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1021\/acs.jnatprod.5b01139","article-title":"Evaluation of the intestinal absorption mechanism of casearin X in Caco-2 cells with modified carboxylesterase activity","volume":"79","author":"Moreira da Silva","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0170","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2006.08.005","article-title":"Is the oral route possible for peptide and protein drug delivery?","volume":"11","author":"Morishita","year":"2006","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2018.07.045","article-title":"Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin","volume":"286","author":"Presas","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0185","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jps.23958","article-title":"In vitro, ex vivo, and in vivo evaluation of the effect of saturated fat acid chain length on the transdermal behavior of ibuprofen-loaded microemulsions","volume":"103","author":"Ren","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2010.07.002","article-title":"Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats","volume":"76","author":"Sharma","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0195","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.ijpharm.2019.02.014_b0200","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2015.05.270","article-title":"Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation","volume":"210","author":"Taverner","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2016.10.002","article-title":"The interaction of protamine nanocapsules with the intestinal epithelium: a mechanistic approach","volume":"243","author":"Thwala","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.014_b0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2016.02.026","article-title":"Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine","volume":"502","author":"Tran","year":"2016","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319301371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319301371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:41:42Z","timestamp":1606524102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517319301371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"alternative-id":["S0378517319301371"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2\/HT29 co-culture monolayers and intra-jejunal instillation in rats","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}